Patients with cirrhosis are at risk of esophageal hemorrhage. The efficacy of endoscopic variceal band ligation (EVBL) for the prophylaxis of initial hemorrhage in patients with cirrhosis is unclear.
A combined therapy of EVL and a nonselective β-blocker is an effective approach for the secondary prophylaxis of patients with variceal hemorrhages Patients with cirrhosis are susceptible to portal ...
Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the ...
PHILADELPHIA — New research challenges the traditional practice of continuing vasoconstrictor therapy for 5 days after endoscopic variceal ligation (EVL) for acute variceal bleeding, finding that a ...
Please provide your email address to receive an email when new articles are posted on . Risks for rebleeding and mortality were similar regardless of vasoconstrictor therapy duration. Data support ...